ITCH involved in cancer progression mainly depends on its ability to regulate protein stability [40–42] and the target proteins including p63 [43], p73 [44], Notch1 [45], Dvl2 [21], RASSF5 [42], and LATS1 [41]. The gene discussed is DVL2; the disease is cancer.